Agentic AI APQR in pharma
LG CNS · Operations & Productivity
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
LG CNS’s Agentic AI APQR in pharma provides the most convenient and efficient service for generating APQR reports. It significantly reduces the time required for data collection and processing—from what used to take several months using manual or semi-automated methods—allowing customers to focus their investments on enhancing the quality of the reports themselves.
LG CNS’s Agentic AI APQR in pharma is a service that manages the entire process—from collecting raw data scattered across various systems such as EDMS, LIMS, ERP, and QMS, as well as handwritten paper documents, to preprocessing and final report generation. To support APQR generation, agents are structured around the planning, execution, and verification phases. Each execution unit corresponds to the detailed business process segments defined within the PQR.
Show the rest of the publisher’s description (1 more line)
This service leverages a managed infrastructure based on Amazon EKS to easily deploy and reliably operate multiple Agent services. Generative AI-based Agents are implemented using Amazon Bedrock, which enables integrated management of models and knowledge bases, while automating the full process from execution planning to operation and evaluation. Model responses are cached using Amazon ElastiCache, improving response times and enabling cost optimization. Context data between Agents is shared via Amazon S3 or Amazon RDS, ensuring session continuity and data consistency. For data collection and processing, Amazon Athena provides a fast and scalable data pipeline. In addition, high-accuracy search functionality is implemented through Retrieval-Augmented Generation (RAG) using OpenSearch, which is effectively applied to the management of GMP and SOP documents — critical compliance requirements in the pharmaceutical industry. User authentication is securely and scalably managed through Amazon Cognito, enhancing both the security and user experience of the overall application.
Highlights
Highlighted by the publisher on AWS Marketplace.
Improvement of your business cost-efficiency - It significantly shortens the volume and preparation time of APQR documents, which require substantial resources annually in the pharmaceutical industry, while enhancing report quality.
Building your high qualty assets - The Agentic AI APQR in pharma delivers sophisticated capabilities that ensure higher accuracy and greater reliability in the generation of final APQR documents.
Enhancement of the operational efficiency and data-driven compliance by APQR multi-agent service.
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Sources
Linked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.